JP2007526891A5 - - Google Patents

Download PDF

Info

Publication number
JP2007526891A5
JP2007526891A5 JP2006518502A JP2006518502A JP2007526891A5 JP 2007526891 A5 JP2007526891 A5 JP 2007526891A5 JP 2006518502 A JP2006518502 A JP 2006518502A JP 2006518502 A JP2006518502 A JP 2006518502A JP 2007526891 A5 JP2007526891 A5 JP 2007526891A5
Authority
JP
Japan
Prior art keywords
antibody
amino acid
fzd10
seq
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006518502A
Other languages
English (en)
Japanese (ja)
Other versions
JP4691626B2 (ja
JP2007526891A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2004/002144 external-priority patent/WO2005004912A1/en
Publication of JP2007526891A publication Critical patent/JP2007526891A/ja
Publication of JP2007526891A5 publication Critical patent/JP2007526891A5/ja
Application granted granted Critical
Publication of JP4691626B2 publication Critical patent/JP4691626B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006518502A 2003-07-11 2004-02-24 滑膜肉腫の治療方法 Expired - Lifetime JP4691626B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48619503P 2003-07-11 2003-07-11
US60/486,195 2003-07-11
PCT/JP2004/002144 WO2005004912A1 (en) 2003-07-11 2004-02-24 Method for treating synovial sarcoma

Publications (3)

Publication Number Publication Date
JP2007526891A JP2007526891A (ja) 2007-09-20
JP2007526891A5 true JP2007526891A5 (enExample) 2007-12-06
JP4691626B2 JP4691626B2 (ja) 2011-06-01

Family

ID=34062116

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006518502A Expired - Lifetime JP4691626B2 (ja) 2003-07-11 2004-02-24 滑膜肉腫の治療方法

Country Status (5)

Country Link
EP (1) EP1648506B1 (enExample)
JP (1) JP4691626B2 (enExample)
AT (1) ATE545658T1 (enExample)
ES (1) ES2381841T3 (enExample)
WO (1) WO2005004912A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803370B2 (en) 2002-08-30 2010-09-28 Oncotherapy Science, Inc. Method for treating synovial sarcoma
EP1561759B9 (en) 2002-10-11 2009-08-26 Chugai Seiyaku Kabushiki Kaisha Cell death-inducing agent
JP5085322B2 (ja) 2005-06-10 2012-11-28 中外製薬株式会社 sc(Fv)2を含有する医薬組成物
WO2006132363A1 (ja) 2005-06-10 2006-12-14 Chugai Seiyaku Kabushiki Kaisha メグルミンを含有するタンパク質製剤の安定化剤、およびその利用
DK2481756T3 (en) * 2005-10-31 2017-10-09 Oncomed Pharm Inc Compositions and Methods for Diagnosing and Treating Cancer
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
EP2044123B1 (en) * 2006-06-21 2013-03-13 Oncotherapy Science, Inc. Tumor-targeting monoclonal antibodies to fzd10 and uses thereof
BRPI0718850A2 (pt) * 2006-11-14 2014-02-25 Novartis Ag Métodos de tratar, diagnosticar ou detectar câncer
CL2008000719A1 (es) * 2007-03-12 2008-09-05 Univ Tokushima Chugai Seiyaku Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a
CN105079805A (zh) 2008-09-26 2015-11-25 昂考梅德药品有限公司 卷曲蛋白结合药剂及其应用
TWI535445B (zh) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Wnt拮抗劑及治療和篩選方法
NZ602700A (en) 2010-04-01 2014-10-31 Oncomed Pharm Inc Frizzled-binding agents and uses thereof
JP6081995B2 (ja) 2011-06-17 2017-02-15 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 癌の処置における治療抗体の標的としてのFrizzled2
JP5944994B2 (ja) * 2011-08-12 2016-07-05 オメロス コーポレーション 抗fzd10モノクローナル抗体およびそれらの使用方法
JP6155255B2 (ja) * 2012-04-17 2017-06-28 Hoya株式会社 Fzd10結合性ペプチド
WO2014066328A1 (en) 2012-10-23 2014-05-01 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using wnt pathway-binding agents
AU2014212081A1 (en) 2013-02-04 2015-08-13 Oncomed Pharmaceuticals, Inc. Methods and monitoring of treatment with a Wnt pathway inhibitor
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
TWI762516B (zh) * 2016-10-06 2022-05-01 日商腫瘤療法 科學股份有限公司 針對fzd10之單株抗體及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
GB9414580D0 (en) * 1994-07-19 1994-09-07 Cancer Res Campaign Tech Materials and methods relating to the diagnosis of synovial sarcomas
US5994098A (en) * 1997-06-02 1999-11-30 Smithkline Beecham Corporation Human 7-TM receptor similar to murine frizzled-6 gene
EP0943684A3 (en) * 1998-03-10 2002-01-23 Smithkline Beecham Plc Frizzled-like polypeptides and polynucleotides
GB9819681D0 (en) * 1998-09-09 1998-11-04 Smithkline Beecham Plc Novel compounds
JP2005508133A (ja) * 2001-01-11 2005-03-31 キュラジェン コーポレイション タンパク質およびそれをコードする核酸
US20030044409A1 (en) * 2001-05-01 2003-03-06 Carson Dennis A. Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens

Similar Documents

Publication Publication Date Title
JP2007526891A5 (enExample)
JP2005528099A5 (enExample)
JP2010516708A5 (enExample)
JP2007527406A5 (enExample)
JP2018198596A5 (enExample)
JP2020526478A5 (enExample)
US20200291134A1 (en) Methods and compositions for the generation and use of conformation-specific antibodies
JP2011526785A5 (enExample)
US20100036101A1 (en) Antibodies against non functional p2x7 receptor
US20150111250A1 (en) Methods and compositions for modulating tumor cell activity
JP2011528561A5 (enExample)
JP2009517057A5 (enExample)
RU2009101788A (ru) Направленные на опухоль моноклональные антитела против fzd10 и их применение
JP2012012402A5 (enExample)
JP2018504105A5 (enExample)
NZ597067A (en) Monoclonal antibodies expressed by ATCC PTA-4621 for the treatment of cancer
RU2014149332A (ru) Антитела против клаудина 18.2 для диагностики рака
RU2009120052A (ru) Композиции и способы связывания сфингозин-1-фосфата
JP2010523096A5 (enExample)
RU2010129558A (ru) ЭЛЕМЕНТ, СВЯЗЫВАЮЩИЙСЯ С АЛЬФА-РЕЦЕПТОРОМ ИНТЕРЛЕЙКИНА-4 (IL-4Rα)-173
JP6081699B2 (ja) Il−28bの分析方法
JP2015506912A5 (enExample)
CA2711863C (en) Antibody directed against pcrv
JP2011526249A5 (enExample)
TW201713700A (zh) 抗glypican-3抗體及其用於診斷及治療癌症之用途